New anti-counterfeiting group to target public health, not trade
This article was originally published in Clinica
The World Health Organization (WHO) is to convene an intergovernmental working group on counterfeit medical products to examine public health – though not trade or IP-related – concerns. The measure was proposed by a WHO working group and approved by the World Health Assembly, on 21 May.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.